Australian & New Zealand Childrens Haematology/Oncology Group
Study Title
A phase I study of vinorelbine, cyclophosphamide and Rapamycin for recurrent malignancies in children
Protocol ID
ACCT007 (Rap-CV)
Disease (Sub Disease)
Malignancies
Diagnosis Stage
Relapsed/refractory
Sponsor
Australian and New Zealand Children's Haematology Oncology Group
Links
Trial Status
Closed to Recruitment
Study Type
Treatment
Phase
Phase 1
Age Eligibility
up to 21 Years
ANZCTR
ACTRN12613000423718
| Study Title | A phase I study of vinorelbine cyclophosphamide and Rapamycin for recurrent malignancies in children |
|---|---|
| Protocol ID | ACCT007 (Rap-CV) |
| Disease (Sub Disease) | Malignancies |
| Diagnosis Stage | Relapsed/refractory |
| Sponsor | Australian and New Zealand Children's Haematology Oncology Group |
| Links | http://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12613000423718 |
| Trial Status | Closed to Recruitment |
| Trial Open Date | 09/08/2019 |
| Study Type | Treatment |
| Phase | Phase 1 |
| Age Eligibility | up to 21 Years |
| ANZCTR | ACTRN12613000423718 |